149 related articles for article (PubMed ID: 9263125)
41. Comparative effects of insulin on the activation of the Raf/Mos-dependent MAP kinase cascade in vitellogenic versus postvitellogenic Xenopus oocytes.
Chesnel F; Bonnec G; Tardivel A; Boujard D
Dev Biol; 1997 Aug; 188(1):122-33. PubMed ID: 9245517
[TBL] [Abstract][Full Text] [Related]
42. Post-translational modification of H-Ras is required for activation of, but not for association with, B-Raf.
Okada T; Masuda T; Shinkai M; Kariya K; Kataoka T
J Biol Chem; 1996 Mar; 271(9):4671-8. PubMed ID: 8617731
[TBL] [Abstract][Full Text] [Related]
43. The cysteine-rich region of raf-1 kinase contains zinc, translocates to liposomes, and is adjacent to a segment that binds GTP-ras.
Ghosh S; Xie WQ; Quest AF; Mabrouk GM; Strum JC; Bell RM
J Biol Chem; 1994 Apr; 269(13):10000-7. PubMed ID: 8144497
[TBL] [Abstract][Full Text] [Related]
44. Characterization of a 78-residue fragment of c-Raf-1 that comprises a minimal binding domain for the interaction with Ras-GTP.
Scheffler JE; Waugh DS; Bekesi E; Kiefer SE; LoSardo JE; Neri A; Prinzo KM; Tsao KL; Wegrzynski B; Emerson SD
J Biol Chem; 1994 Sep; 269(35):22340-6. PubMed ID: 8071362
[TBL] [Abstract][Full Text] [Related]
45. A novel potential effector of M-Ras and p21 Ras negatively regulates p21 Ras-mediated gene induction and cell growth.
Ehrhardt GR; Korherr C; Wieler JS; Knaus M; Schrader JW
Oncogene; 2001 Jan; 20(2):188-97. PubMed ID: 11313946
[TBL] [Abstract][Full Text] [Related]
46. Different effects of various phospholipids on Ki-Ras-, Ha-Ras-, and Rap1B-induced B-Raf activation.
Kuroda S; Ohtsuka T; Yamamori B; Fukui K; Shimizu K; Takai Y
J Biol Chem; 1996 Jun; 271(25):14680-3. PubMed ID: 8663012
[TBL] [Abstract][Full Text] [Related]
47. Three-dimensional structure of the Ras-interacting domain of RalGDS.
Huang L; Weng X; Hofer F; Martin GS; Kim SH
Nat Struct Biol; 1997 Aug; 4(8):609-15. PubMed ID: 9253406
[TBL] [Abstract][Full Text] [Related]
48. Allosteric effects of the oncogenic RasQ61L mutant on Raf-RBD.
Fetics SK; Guterres H; Kearney BM; Buhrman G; Ma B; Nussinov R; Mattos C
Structure; 2015 Mar; 23(3):505-516. PubMed ID: 25684575
[TBL] [Abstract][Full Text] [Related]
49. Evidence that the ras oncogene-encoded p21 protein induces oocyte maturation via activation of protein kinase C.
Chung DL; Brandt-Rauf PW; Weinstein IB; Nishimura S; Yamaizumi Z; Murphy RB; Pincus MR
Proc Natl Acad Sci U S A; 1992 Mar; 89(5):1993-6. PubMed ID: 1542698
[TBL] [Abstract][Full Text] [Related]
50. KRAS interaction with RAF1 RAS-binding domain and cysteine-rich domain provides insights into RAS-mediated RAF activation.
Tran TH; Chan AH; Young LC; Bindu L; Neale C; Messing S; Dharmaiah S; Taylor T; Denson JP; Esposito D; Nissley DV; Stephen AG; McCormick F; Simanshu DK
Nat Commun; 2021 Feb; 12(1):1176. PubMed ID: 33608534
[TBL] [Abstract][Full Text] [Related]
51. Stimulation of mitogen-activated protein kinase by oncogenic Ras p21 in Xenopus oocytes. Requirement for Ras p21-GTPase-activating protein interaction.
Pomerance M; Schweighoffer F; Tocque B; Pierre M
J Biol Chem; 1992 Aug; 267(23):16155-60. PubMed ID: 1322893
[TBL] [Abstract][Full Text] [Related]
52. The dominant negative effects of H-Ras harboring a Gly to Ala mutation at position 60.
Sung YJ; Hwang MC; Hwang YW
J Biol Chem; 1996 Nov; 271(48):30537-43. PubMed ID: 8940023
[TBL] [Abstract][Full Text] [Related]
53. Ras-interacting domain of Ral GDP dissociation stimulator like (RGL) reverses v-Ras-induced transformation and Raf-1 activation in NIH3T3 cells.
Okazaki M; Kishida S; Murai H; Hinoi T; Kikuchi A
Cancer Res; 1996 May; 56(10):2387-92. PubMed ID: 8625316
[TBL] [Abstract][Full Text] [Related]
54. An intact Raf zinc finger is required for optimal binding to processed Ras and for ras-dependent Raf activation in situ.
Luo Z; Diaz B; Marshall MS; Avruch J
Mol Cell Biol; 1997 Jan; 17(1):46-53. PubMed ID: 8972184
[TBL] [Abstract][Full Text] [Related]
55. Mechanism of inhibition of Raf-1 by protein kinase A.
Häfner S; Adler HS; Mischak H; Janosch P; Heidecker G; Wolfman A; Pippig S; Lohse M; Ueffing M; Kolch W
Mol Cell Biol; 1994 Oct; 14(10):6696-703. PubMed ID: 7935389
[TBL] [Abstract][Full Text] [Related]
56. The minimal fragments of c-Raf-1 and NF1 that can suppress v-Ha-Ras-induced malignant phenotype.
Fridman M; Tikoo A; Varga M; Murphy A; Nur-E-Kamal MS; Maruta H
J Biol Chem; 1994 Dec; 269(48):30105-8. PubMed ID: 7982912
[TBL] [Abstract][Full Text] [Related]
57. Site-specific phosphorylation of raf in cells containing oncogenic ras-p21 is likely mediated by jun-N-terminal kinase.
Adler V; Bowne W; Michl J; Sookraj KA; Ikram K; Pestka S; Izotova L; Zenilman M; Friedman FK; Qu Y; Pincus MR
Ann Clin Lab Sci; 2008; 38(1):47-56. PubMed ID: 18316782
[TBL] [Abstract][Full Text] [Related]
58. Raf-1 is involved in the regulation of the interaction between guanine nucleotide exchange factor and Ha-ras. Evidences for a function of Raf-1 and phosphatidylinositol 3-kinase upstream to Ras.
Giglione C; Parmeggiani A
J Biol Chem; 1998 Dec; 273(52):34737-44. PubMed ID: 9856997
[TBL] [Abstract][Full Text] [Related]
59. Complex formation between RAS and RAF and other protein kinases.
Van Aelst L; Barr M; Marcus S; Polverino A; Wigler M
Proc Natl Acad Sci U S A; 1993 Jul; 90(13):6213-7. PubMed ID: 8327501
[TBL] [Abstract][Full Text] [Related]
60. Pathways for activation of the ras-oncogene-encoded p21 protein.
Pincus MR; Chung D; Dykes DC; Brandt-Rauf P; Weinstein IB; Yamaizumi Z; Nishimura S
Ann Clin Lab Sci; 1992; 22(5):323-42. PubMed ID: 1524403
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
